PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 29, 2026ACS Chemical Neuroscience0 citationsOpen Access

Serotonin Transporter Blockade Reduces the Psychedelic-Like Effects of 4-Methoxy- N -methyl- N -isopropyltryptamine and Related Analogs

View Full Paper
GGGrant C. GlatfelterSSSerena S. SchalkDWDonna Walther

Key Points

  • This study aims to evaluate how serotonin transporter blockade affects the psychedelic-like effects of different tryptamine analogs.
  • In vitro assessment of 5-HT receptor activities for various compounds
  • Administration of substances subcutaneously to C57BL/6J mice
  • Comparison of head twitch response induced by analogs of 4-MeO-MiPT with and without SERT inhibitor
  • 4-MeO-MiPT displayed reduced efficacy in inducing head twitch responses (Emax = 34 HTRs/30 min) compared to 4-HO-MiPT (Emax = 77 HTRs/30 min)
  • Fluoxetine pretreatment decreased head twitch responses to levels similar to 4-MeO analogs
  • 4-MeO-MiPT and its related analogs exhibited more potent SERT inhibition than 4-OH derivatives (IC50 = 17–107 nM vs 280–423 nM)

Abstract

Tryptamine psychedelics induce psychoactive effects via agonist actions at serotonin 2A receptors (5-HT2A), but the compounds are generally nonselective. 4-Methoxy-N-methyl-N-isopropyltryptamine (4-MeO-MiPT) is a 5-HT2A agonist which also blocks the 5-HT transporter (SERT) and has blunted visual and other psychedelic effects in humans. Here, we compared the pharmacology of 4-MeO-MiPT, its 4-hydroxy derivative (4-HO-MiPT), and related analogs with N-alkyl or 4-alkoxy variations. We hypothesized that compounds with more potent SERT uptake inhibition would display reduced 5-HT2A-mediated psychedelic-like effects in the mouse head twitch response (HTR) model. In vitro target profiling revealed potent and efficacious 5-HT receptor activities for most of the compounds, including 5-HT2A receptor agonism (EC50 = 10–118 nM, Emax = 72–97% 5-HT). Importantly, 4-MeO-MiPT and its N,N-diisopropyl (4-MeO-DiPT) and N-methyl-N-cyclopropyl (4-MeO-McPT) analogs displayed more potent uptake inhibition at SERT (IC50 = 17–107 nM) than their 4-OH counterparts (IC50 = 280–423 nM). Studies administering the drugs subcutaneously to C57BL/6J mice revealed that 4-HO- and 4-MeO-MiPT (0.03–30 mg/kg) had similar potencies for inducing HTRs (ED50 = 0.75 vs 0.97 mg/kg), but 4-MeO-MiPT had reduced efficacy (Emax = 77 vs 34 HTRs/30 min). A similar trend for decreased HTRs was observed for 4-MeO-DiPT and 4-MeO-McPT. Pretreatment with the SERT inhibitor fluoxetine (10 mg/kg) prior to 4-HO-MiPT, 4-HO-DiPT, or 4-HO-McPT reduced the maximal number of HTRs to levels observed for their respective 4-MeO analogs. Overall, our data indicate that 4-MeO-MiPT interacts with 5-HT2A and other 5-HT receptors, but the drug also inhibits SERT to reduce the efficacy of psychedelic-like effects in mice. Therefore, 4-MeO-MiPT and other dual 5-HT2A/SERT ligands may be therapeutically relevant compounds with reduced potential for traditional acute psychedelic effects.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Glatfelter et al. (2026) studied this question.

synapsesocial.com/papers/6a192e39fab5b468c44172efhttps://doi.org/10.1021/acschemneuro.6c00083
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Concomitant use of antidepressants and classic psychedelics: A scoping review2025 · 6 citations
  2. 2Drug concentrations in mouse brain at pharmacologically active doses of fluoxetine enantiomers1993 · 22 citations
  3. 3Elusive equilibrium: the challenge of interpreting receptor pharmacology using calcium assays2010 · 112 citations
  4. 4SnapShot: Psychedelics and serotonin receptor signaling2023 · 14 citations
  5. 5Postnatal Fluoxetine-Evoked Anxiety Is Prevented by Concomitant 5-HT2A/C Receptor Blockade and Mimicked by Postnatal 5-HT2A/C Receptor Stimulation2013 · 74 citations